Benzamide → HCID 66830407, compound
Reaction equation
Cl[C:2]1[N:7]=[C:6]([NH:8][C:9]2[CH:18]=[CH:17][CH:16]=[CH:15][C:10]=2[C:11](NC)=[O:12])[C:5]([Cl:19])=[CH:4][N:3]=1.[NH2:20][C:21]1[C:35]([O:36][CH3:37])=[CH:34][C:24]2[CH2:25][CH2:26][N:27]([CH2:30][CH:31]([OH:33])[CH3:32])[CH2:28][CH2:29][C:23]=2[CH:22]=1.C(N)(=O)C1C=CC=CC=1.[CH3:47][O:48][CH2:49][CH2:50][OH:51]>>[CH3:47][O:48][CH2:49][CH2:50][O:51][C:11](=[O:12])[C:10]1[CH:15]=[CH:16][CH:17]=[CH:18][C:9]=1[NH:8][C:6]1[C:5]([Cl:19])=[CH:4][N:3]=[C:2]([NH:20][C:21]2[C:35]([O:36][CH3:37])=[CH:34][C:24]3[CH2:25][CH2:26][N:27]([CH2:30][CH:31]([OH:33])[CH3:32])[CH2:28][CH2:29][C:23]=3[CH:22]=2)[N:7]=1Participants
5
Procedure
In an analogous manner to Example 1534, the product was prepared from 2-(2,5-Dichloro-pyrimidin-4-ylamino)-N-methyl-benzamide and 1-(7-Amino-8-methoxy-1,2,4,5-tetrahydro-3-benzazepin-3-yl)-propan-2-ol. The 2-methoxyethanol solvent reacted with the benzamide resulting in the product (28 mg, 25%). mp: 100° C., MS (ESI+): 556 (M+H), 1H-NMR (CDCl3, 400 MHz) δ 11.03 (s, 1H), 8.86 (d, J=8.6 Hz, 1H), 8.17 (s, 2H), 8.15 (s, 1H), 7.53 (t, J=8.1 Hz, 1H), 7.49 (s, 2H), 7.11 (t, J=7.2 Hz, 1H), 6.68 (s, 1H), 4.55 (t, J=8.6 Hz, 2H), 3.90 (s, 4H), 3.79 (t, 2H), 3.46 (m, 2H), 2.96-2.82 (m, 6H), 2.62 (m, 2H), 2.61 (d, J=10 Hz, 1H), 2.27 (t, J=9 Hz, 1H), 1.17 (d, J=6 Hz, 3H).
Sources & evidence
- ORD record
- ord-d5eb6701dcd14e8e817b283212e78b23
- Source dataset
- uspto-grants-2013_10
- Patent number
- US08552186B2
Reaction notes
Loading…